Advertisement

Disruptors

London-based artificial intelligence company DeepMind, which is owned by Google's parent company Alphabet, is training its software to fold proteins for drug discovery, reports Bloomberg.

DeepMind, Google's artificial intelligence arm, launched an ethics and society research unit to evaluate its breakthroughs in AI science and application, according to a company blog post.

Advertisement

Gaining market power on both the provider and payer sides of healthcare has been the name of the game in recent years. In fact, consolidation has become so pervasive that partners have been increasingly likely to attempt dubious mergers, according…

Advertisement